Nucleic Acid Therapeutics CDMO Market, By Type (Plasmid DNA, Antisense Oligonucleotides, siRNA Therapeutics, mRNA Therapeutics, Gene Therapy, and Viral Vector-based Products), By Service, By End Use, By Application, By Country, and By Region –Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV1807
|
Published Date
April 2026
|
Pages
343
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Nucleic Acid Therapeutics CDMO market size was valued at US$ 17,508.3 Million in 2025, expanding at a CAGR of 14.3% from 2026 to 2033.
Nucleic acid drugs are a class of synthetic oligonucleotide-based therapeutics composed of DNA, RNA, or nucleotide analogs with precisely defined sequences. These molecules are designed to bind selectively to target genetic material through Watson–Crick base pairing, enabling highly specific interaction with disease-related genes. Structural modifications such as phosphorothioate backbone linkages or sugar modifications like 2’-O-methyl and locked nucleic acids (LNAs) enhance their stability, bioavailability, and resistance to enzymatic degradation. These therapeutic agents work by regulating gene expression through mechanisms such as antisense inhibition, RNA interference (RNAi), or splice-site modulation, allowing precise control over protein production at the molecular level. As a result, nucleic acid-based therapies are emerging as a powerful approach for targeted and personalized disease treatment strategies. According to the World Health Organization (WHO), noncommunicable diseases are responsible for approximately 74% of global deaths each year, highlighting the growing need for advanced targeted therapies. This rising disease burden continues to drive interest and investment in next-generation treatments such as nucleic acid drugs, which offer highly specific and mechanism-based therapeutic intervention.
Nucleic Acid Therapeutics CDMO Market- Market Dynamics
Increasing Adoption of RNA-Based Therapeutics Driving Market Growth
The rapid growth of RNA-based therapeutics is a major factor driving the expansion of the nucleic acid therapeutics CDMO market, as demand increases for specialized development and manufacturing capabilities. Advances in technologies such as mRNA, siRNA, antisense oligonucleotides (ASOs), and RNA editing have significantly broadened the scope of RNA-based drug development and accelerated clinical translation. According to a comprehensive review published in the U.S. National Library of Medicine (PMC, 2026), more than 20 RNA-based therapeutics have already received regulatory approval globally, while many others are progressing through Phase I, II, and III clinical trials for indications including cancer, genetic disorders, infectious diseases, and metabolic conditions. This expanding clinical pipeline is significantly increasing the need for advanced contract development and manufacturing organization (CDMO) services to support scalable, high-quality production of RNA-based therapies worldwide.
Nucleic Acid Therapeutics CDMO Market- Segmentation Analysis:
The Global Nucleic Acid Therapeutics CDMO market is segmented on the basis of Type, Service, End Use, Application, and Region.
Among the key application areas, infectious diseases account for a significant share of the nucleic acid therapeutics market, driven by the increasing demand for advanced treatments targeting viral, bacterial, and emerging infections. Continuous advancements in RNA- and DNA-based drug development have strengthened the ability to design precise, mechanism-based therapies, improving the speed and effectiveness of treatment innovation. In May 2025, Aldevron, a Danaher company, collaborated with Integrated DNA Technologies to advance the development of a personalized CRISPR-based therapy utilizing mRNA-enabled manufacturing platforms for DNA and RNA production. This initiative supports the evolution of next-generation nucleic acid medicines aimed at addressing both genetic and infectious diseases. Such developments are expected to accelerate innovation and broaden the global adoption of nucleic acid therapeutics in the coming years.
Nucleic Acid Therapeutics CDMO Market- Geographical Insights
North America holds a dominant position in the nucleic acid therapeutics CDMO market, supported by a favorable regulatory framework, rising investment activity, and an increasing number of product approvals. The region benefits from a strong biopharmaceutical ecosystem that encourages innovation and accelerates the development and commercialization of advanced nucleic acid-based therapies.
According to the National Academies of Sciences, Engineering, and Medicine (2026), there is growing emphasis on aligning therapeutic innovation investments with disease burden and unmet medical needs. The initiative brings together a multidisciplinary panel of 16 experts from healthcare, biopharmaceutical, and policy sectors to assess how research and development funding can be more effectively directed toward high-priority health challenges. This continued focus on targeted investment is expected to strengthen innovation pipelines and support sustained growth of the nucleic acid therapeutics CDMO market in North America.
India Nucleic Acid Therapeutics CDMO market - Country Insights
The India nucleic acid therapeutics CDMO market is expected to witness strong growth, supported by cost-efficient manufacturing capabilities, a skilled scientific workforce, and a robust network of WHO-cGMP-compliant production facilities. These strengths position India as an emerging global hub for contract development and manufacturing services in advanced therapeutics, including nucleic acid-based drugs.
According to the Central Drugs Standard Control Organization (CDSCO), India currently has 2,006 WHO-cGMP-certified pharmaceutical manufacturing facilities distributed across various states. Gujarat leads with 684 certified facilities, followed by Maharashtra with 229, Himachal Pradesh with 202, Telangana with 172, and Uttarakhand with 128 units. This well-established regulatory-compliant manufacturing ecosystem reinforces India’s position as a preferred destination for nucleic acid therapeutics CDMO services and supports its growing role in the global biopharmaceutical supply chain.
Nucleic Acid Therapeutics CDMO Market- Competitive Landscape:
Leading companies in the global market, including LGC Limited, Merck KGaA, WuXi AppTec, BIOSPRING, and Univercells Inc., are actively pursuing strategic growth initiatives. These organizations are focusing on collaborations, acquisitions, capacity expansions, and the launch of new service offerings to strengthen their market share, technological capabilities, and global presence. In October 2025, BIOSPRING launched manufacturing services for Luxna Biotech’s XNA amidite portfolio, which includes AmNA™, scpBNA™, and 5’-CP™ chemistries. This initiative is expected to enhance BIOSPRING’s contract development and manufacturing organization (CDMO) services for therapeutic oligonucleotides by supporting advanced nucleic acid medicines with improved affinity, greater stability, and reduced toxicity. Overall, this development is expected to accelerate innovation across the nucleic acid therapeutics sector.
Recent Developments
- In June 2026, Merck KGaA agreed to acquire Bio-Techne Corporation for approximately USD 11.3 billion, significantly expanding its life sciences business. The acquisition strengthens Merck’s portfolio of research reagents, proteins, antibodies, and analytical tools used in biopharmaceutical and nucleic acid therapeutic development.
- In March 2026, Agilent Technologies launched Agilent Advanced Therapeutics, integrating its nucleic acid manufacturing and CDMO capabilities to deliver end-to-end oligonucleotide development and production services. The platform supports advanced therapeutic programs, including nucleic acid-based treatments for infectious diseases.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Agilent Technologies, Inc.
- Curia Global, Inc.
- Ajinomoto Co., Inc.
- Danaher Corporation
- Aldevron
- Integrated DNA Technologies (IDT)
- KNC Laboratories Co., Ltd.
- LGC Limited
- Axolabs GmbH
- Merck KGaA
- WuXi AppTec Co., Ltd.
- BioSpring GmbH
- Univercells Inc.
- Exothera SA
- AGC Biologics, Inc.
- Asymchem Inc.
- Bachem AG
- BioCina
- CMIC HOLDINGS Co., Ltd.
- Eurofins Scientific SE
- Kaneka Corporation
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Plasmid DNA
- Antisense Oligonucleotides
- siRNA Therapeutics
- mRNA Therapeutics
- Gene Therapy
- Viral Vector-based Products
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY SERVICE- MARKET ANALYSIS, 2020 - 2033
- Process Development and Optimization
- Manufacturing Services
- Analytical and Quality Control Services
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033
- Pharmaceutical Companies
- Biotech Companies
- Government & Academic Research Institutes
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Genetic Disorders
- Infectious Diseases
- Oncology
- Metabolic Disorders
- Rare Diseases
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Nucleic Acid Therapeutics CDMO Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Nucleic Acid Therapeutics CDMO Market Snippet by Type
2.1.2. Nucleic Acid Therapeutics CDMO Market Snippet by Service
2.1.3. Nucleic Acid Therapeutics CDMO Market Snippet by End Use
2.1.4. Nucleic Acid Therapeutics CDMO Market Snippet by Application
2.1.5. Nucleic Acid Therapeutics CDMO Market Snippet by Country
2.1.6. Nucleic Acid Therapeutics CDMO Market Snippet by Region
2.2. Competitive Insights
3. Nucleic Acid Therapeutics CDMO Key Market Trends
3.1. Nucleic Acid Therapeutics CDMO Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Nucleic Acid Therapeutics CDMO Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Nucleic Acid Therapeutics CDMO Market Opportunities
3.4. Nucleic Acid Therapeutics CDMO Market Future Trends
4. Nucleic Acid Therapeutics CDMO Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Nucleic Acid Therapeutics CDMO Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Nucleic Acid Therapeutics CDMO Market Landscape
6.1. Nucleic Acid Therapeutics CDMO Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Nucleic Acid Therapeutics CDMO Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
7.1.2. Plasmid DNA
7.1.3. Antisense Oligonucleotides
7.1.4. siRNA Therapeutics
7.1.5. mRNA Therapeutics
7.1.6. Gene Therapy
7.1.7. Viral Vector-based Products
7.1.8. Others
8. Nucleic Acid Therapeutics CDMO Market – By Service
8.1. Overview
8.1.1. Segment Share Analysis, By Service, 2025 & 2033 (%)
8.1.2. Process Development and Optimization
8.1.3. Manufacturing Services
8.1.4. Analytical and Quality Control Services
8.1.5. Others
9. Nucleic Acid Therapeutics CDMO Market – By End Use
9.1. Overview
9.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
9.1.2. Pharmaceutical Companies
9.1.3. Biotech Companies
9.1.4. Government & Academic Research Institutes
9.1.5. Others
10. Nucleic Acid Therapeutics CDMO Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
10.1.2. Genetic Disorders
10.1.3. Infectious Diseases
10.1.4. Oncology
10.1.5. Metabolic Disorders
10.1.6. Rara Diseases
10.1.7. Others
11. Nucleic Acid Therapeutics CDMO Market – By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Nucleic Acid Therapeutics CDMO Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Agilent Technologies, Inc.
12.2.2. Curia Global, Inc.
12.2.3. Ajinomoto Co., Inc.
12.2.4. Danaher Corporation
12.2.5. Aldevron
12.2.6. Integrated DNA Technologies (IDT)
12.2.7. KNC Laboratories Co., Ltd.
12.2.8. LGC Limited
12.2.9. Axolabs GmbH
12.2.10. Merck KGaA
12.2.11. WuXi AppTec Co., Ltd.
12.2.12. BioSpring GmbH
12.2.13. Univercells Inc.
12.2.14. Exothera SA
12.2.15. AGC Biologics, Inc.
12.2.16. Asymchem Inc.
12.2.17. Bachem AG
12.2.18. BioCina
12.2.19. CMIC HOLDINGS Co., Ltd.
12.2.20. Eurofins Scientific SE
12.2.21. Kaneka Corporation
12.2.22. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Agilent Technologies, Inc.
- Curia Global, Inc.
- Ajinomoto Co., Inc.
- Danaher Corporation
- Aldevron
- Integrated DNA Technologies (IDT)
- KNC Laboratories Co., Ltd.
- LGC Limited
- Axolabs GmbH
- Merck KGaA
- WuXi AppTec Co., Ltd.
- BioSpring GmbH
- Univercells Inc.
- Exothera SA
- AGC Biologics, Inc.
- Asymchem Inc.
- Bachem AG
- BioCina
- CMIC HOLDINGS Co., Ltd.
- Eurofins Scientific SE
- Kaneka Corporation
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Plasmid DNA
- Antisense Oligonucleotides
- siRNA Therapeutics
- mRNA Therapeutics
- Gene Therapy
- Viral Vector-based Products
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY SERVICE- MARKET ANALYSIS, 2020 - 2033
- Process Development and Optimization
- Manufacturing Services
- Analytical and Quality Control Services
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033
- Pharmaceutical Companies
- Biotech Companies
- Government & Academic Research Institutes
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Genetic Disorders
- Infectious Diseases
- Oncology
- Metabolic Disorders
- Rare Diseases
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS